As of 2026-08-24, Precipio, Inc. Common Stock (PRPO) has a 3-month relative strength percentile of 88 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 63. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 8.4%, relative volume 0.23×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
PRPO is in a stage 3 topping pattern, week 7. Currently in a 76-day base; basing ADR 7.6% (broad 6.1%). VCP detected: inconclusive. RS line below base-start high. Distance from 50d / 200d: 29.8% / 25.7%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
PRPO is held by 3 ETFs as of Apr 2026. Top owner: DFSU at 0.00% weight, $31K notional. Top 3 carry $54K.
Held by 5 ETFs · $691K across latest filings · largest weight 0.00% (DFSU).
Top 3 by value, from SEC N-PORT-P filings dated Apr 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| DFSU | 0.00% | $31K | — |
| DFASDimensional U.S. Small Cap ETF | 0.00% | $19K | new |
| DCOR | 0.00% | $4K | — |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Strong relative strength with attention running hot versus its own recent norm. The trend is intact but well-noticed; elevated retail attention has historically been associated with softer forward returns. Context, not a call.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | PRPO Jan avg: 23.53% median: 15.42% win: 75% σ: 29.68% n: 4 2022-04-12 → 2026-07-31 | PRPO Feb avg: -0.09% median: 1.20% win: 50% σ: 6.64% n: 4 2022-04-12 → 2026-07-31 | PRPO Mar avg: -7.38% median: -6.62% win: 50% σ: 11.46% n: 4 2022-04-12 → 2026-07-31 | PRPO Apr avg: -2.35% median: -8.13% win: 20% σ: 15.06% n: 5 2022-04-12 → 2026-07-31 | PRPO May avg: 6.15% median: 0.18% win: 60% σ: 30.04% n: 5 2022-04-12 → 2026-07-31 | PRPO Jun avg: -4.83% median: -7.02% win: 40% σ: 19.14% n: 5 2022-04-12 → 2026-07-31 | PRPO Jul avg: 2.81% median: -2.50% win: 40% σ: 18.92% n: 5 2022-04-12 → 2026-07-31 | PRPO Aug avg: 8.72% median: 4.26% win: 50% σ: 14.87% n: 4 2022-04-12 → 2026-07-31 (current) | PRPO Sep avg: -7.53% median: -6.43% win: 50% σ: 20.27% n: 4 2022-04-12 → 2026-07-31 | PRPO Oct avg: 12.94% median: 7.99% win: 75% σ: 19.92% n: 4 2022-04-12 → 2026-07-31 | PRPO Nov avg: -1.78% median: -6.32% win: 25% σ: 14.04% n: 4 2022-04-12 → 2026-07-31 | PRPO Dec avg: -11.30% median: -6.16% win: 0% σ: 11.23% n: 4 2022-04-12 → 2026-07-31 |